Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes
Abstract The emerging field of long noncoding RNA (lncRNA)-immunity has provided a new perspective on cancer immunity and immunotherapies. The lncRNA modifiers of infiltrating immune cells in the tumor immune microenvironment (TIME) and their impact on tumor behavior and disease prognosis remain lar...
Main Authors: | Zicheng Zhang, Congcong Yan, Ke Li, Siqi Bao, Lei Li, Lu Chen, Jingting Zhao, Jie Sun, Meng Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-021-00215-7 |
Similar Items
-
Identification of lncRNA Signature Associated with Pan-Cancer Prognosis
by: Bao, G., et al.
Published: (2021) -
Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer
by: Yue Gao, et al.
Published: (2019-12-01) -
LncRNA <i>HOTAIR</i> in Tumor Microenvironment: What Role?
by: Gerardo Botti, et al.
Published: (2019-05-01) -
Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma
by: Zhiyuan Zhang, et al.
Published: (2018-09-01) -
lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
by: Shujun Zhang, et al.
Published: (2021-05-01)